Posts in category: Uncategorized

During the pandemic, nearly 100,000 U.S. registered nurses called it quits, a new survey shows.

A multidisciplinary group of tuberculosis experts from the TBnet and RESIST-TB networks have reached a consensus on key issues related to the molecular prediction of Mycobacterium tuberculosis antibiotic sensitivity or resistance and its clinical implications. The consensus document provides guidance for the design of therapeutic regimens and the optimization of treatments, and is intended to help clinicians manage tuberculosis patients.

When does the COVID-19 pandemic end?

Researchers from the University of Eastern Finland, the University of Turku, and Tampere University have developed an artificial intelligence-based method for virtual staining of histopathological tissue samples as a part of the Nordic ABCAP consortium. Chemical staining has been the cornerstone of studying histopathology for more than a century and is widely applied in, for example, cancer diagnostics.

People with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 in Cancer Medicine.

Interest has exploded in a weight loss drug that was initially developed to help diabetics control their blood sugar.

Arrhythmia, when left unchecked, can be life-threatening.

The Hereditary Cancer research group from the Germans Trias i Pujol Research Institute (IGTP) has led an international collaboration that has allowed the genomic characterization of the most commonly used cell lines derived from malignant peripheral nerve sheath tumors (MPNSTs).

Alzheimer’s disease (AD) can be divided into rare early onset familial AD (fAD) and common late onset sporadic AD (sAD) that impairs the memory and cognitive functions of older people worldwide.

Cancers are notoriously known for their high mortality rate and increasing incidence worldwide. Among them, lung cancer is arguably one of the most devastating. According to the World Cancer Research Fund International, lung cancer was the second most common cancer around the world in 2020, with more than 2.2 million new cases and 1.8 million deaths.